United States· US:0006-3080_70b9b593-db43-43ad-8808-a1c86c048145
ISENTRESS
A raltegravir product containing raltegravir potassium, registered in United States by Merck Sharp & Dohme LLC. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Raltegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AJ01 (raltegravir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Raltegravir · ATC J05AJ01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of raltegravir costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Raltegravir · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$18.61
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RALTEGRAVIR POTASSIUM
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- J05AJ01
- ATC class
- Raltegravir
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11000630800160 TABLET, FILM COATED in 1 BOTTLE (0006-3080-01)
- ndc110006-3080-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for raltegravir.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Raltegravir · interactions on record
55 records
- 15 severe
- 22 moderate
- 18 minor
Most severe, free to view
- Magnesium carbonateA02AA01severe
- Magnesium hydroxideA02AA04severe
- Kombinationen von AluminiumsalzenA02AB10severe
- Calcium carbonateA02AC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Raltegravir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandISENTRESSMerck Sharp & Dohme B.V.
- FranceISENTRESS 600 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- NetherlandsIsentress 600 mg, filmomhulde tabletMerck Sharp & Dohme B.V.
- IcelandIsentressMerck Sharp & Dohme B.V.*
- SwedenISENTRESS 600 mg Filmdragerad tablettMerck Sharp & Dohme BV
- PolandIsentressMerck Sharp & Dohme B.V.
- CzechiaISENTRESSMerck Sharp & Dohme B.V., Haarlem
- NorwayIsentressMerck Sharp & Dohme B.V. (1)
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Bulgaria · Raltegravir Viatris, Ралтегравир Зентива
- Cyprus · Raltegravir Viatris
- Germany · Raltegravir Axiromed, Raltegravir Beta
- Denmark · Raltegravir Viatris, Raltegravir Zentiva
- Estonia · Raltegravir Viatris, Raltegravir Zentiva
- Spain · Raltegravir Dr. Reddys, Raltegravir Zentiva
- Finland · Raltegravir Viatris, Raltegravir Zentiva
- France · Raltegravir Biogaran, Raltégravir Biogaran
- United Kingdom (Northern Ireland) · Raltegravir Amarox, Raltegravir Dr. Reddy's Laboratories (Uk)
- Greece · Ralpecin, Raltegravir Viatris
- Croatia · Raltegravir Viatris
- Iceland · Isentress, Raltegravir Zentiva
- Italy · Raltegravir Dr. Reddy’s, Raltegravir Mylan
- Liechtenstein · Isentress
- Lithuania · Raltegravir Zentiva
- Latvia · Raltegravir Viatris, Raltegravir Zentiva
- Malta · Raltegravir Viatris
- Netherlands · Raltegravir Rockmed Pharma, Raltegravir Viatris
- Norway · Isentress, Raltegravir Viatris
- Poland · Raltegravir Viatris
- Portugal · Raltegravir Mylan, Raltegravir Zentiva
- Romania · Raltegravir Viatris, Raltegravir Zentiva
- Sweden · Raltegravir Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca9397f9-71cd-4e24-b4ca-2acd2c5b9d51 GET /v1/drugs/ca9397f9-71cd-4e24-b4ca-2acd2c5b9d51?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "600",
"substance": "RALTEGRAVIR POTASSIUM",
"productndc": "0006-3080",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA022145",
"marketing_category": "NDA"
}See everything about raltegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.